用CD147向纳米颗粒携带Phenformin的组合疗法降低了肺癌的生长
Andreia Pereira-Nunes1,2, Helena Ferreira2,3, Sara Abreu1,2
1Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
Advanced biology
|June 12, 2023
概括
携带形素的向性脂质体有效地对抗肺癌. 这些新型的抗CD147脂质体 (LUV) 装载着甲抑制癌细胞的生长和入侵,提供了一个有前途的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 生物化学 生物化学
背景情况:
- 肺癌是一个重大的全球健康挑战,治疗选择有限.
- 瘤细胞表现出高糖解,增加乳酸的生产和出口.
- CD147 (基因) 是乳酸运输的关键调节剂,影响癌症的进展.
研究的目的:
- 开发和评估用于肺癌治疗的抗CD147向性脂质体 (LUV),载有芬福明.
- 评估这些LUV在抑制肺癌细胞生长,新陈代谢和侵袭方面的有效性.
主要方法:
- 评估了福明和抗CD147抗体治疗方法.
- 开发了携带甲胺的抗CD147向性脂质体 (LUV).
- 进行了体外 (A549,H292,PC-9细胞) 和体内疗效研究.
主要成果:
- 芬福明显著减少了2D和3D肺癌细胞生长.
- 抗CD147抗体治疗减少了癌细胞的入侵.
- 携带芬福明的抗CD147LUV被癌细胞内化,并有效地抑制了体外和体内肺癌的生长.
结论:
- 充满芬福明的抗CD147LUVs代表了对抗肺癌的有效策略.
- 这种有针对性的药物输送系统在克服治疗耐药性和减少癌症的攻击性方面显示出有希望.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.7K
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K